Globus Medical Inc. logo

Globus Medical Inc. (GMED)

Market Closed
15 Jun, 20:00
NYSE NYSE
$
77. 30
-3.09
-3.8438%
After Hours
$
79. 22
+1.92 +2.4838%
10.84B Market Cap
48.4 P/E Ratio
- Div Yield
1.13M Volume
2.69 Eps
$ 80.39
Previous Close
Analysts:
Add Transaction
Day Range
76.61 80.8
Year Range
51.79 101.4
Want to track GMED and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term

Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Globus Medical Surges 62.1% in a Year: What's Driving the Stock?

Globus Medical Surges 62.1% in a Year: What's Driving the Stock?

GMED's strong synergies from the NuVasive merger and robust performance in the musculoskeletal solutions space bode well for investors.

Zacks | 1 year ago
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
Here's Why Globus Medical (GMED) is a Strong Growth Stock

Here's Why Globus Medical (GMED) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.

Zacks | 1 year ago
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Reasons to Add GMED Stock to Your Portfolio Right Now

Reasons to Add GMED Stock to Your Portfolio Right Now

Globus Medical's synergistic merger with NuVasive and a strong liquidity position bring optimism to investors.

Zacks | 1 year ago
What Makes Globus Medical (GMED) a New Buy Stock

What Makes Globus Medical (GMED) a New Buy Stock

Globus Medical (GMED) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 year ago
Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Here's Why Globus Medical (GMED) is a Strong Value Stock

Here's Why Globus Medical (GMED) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)

3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)

Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.

Zacks | 1 year ago
GMED vs. PEN: Which Stock Should Value Investors Buy Now?

GMED vs. PEN: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 1 year ago
Loading...
Load More